INVO Bioscience, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Bioscience, Inc. (trading symbol: IVOB) on December 19, 2019, reporting events that occurred on December 16, 2019. The filing details the results of the Company's annual meeting of stockholders and the election of new directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes rather than financial performance.
Material Changes and Corporate Actions
On December 16, 2019, the Company held its annual meeting of stockholders. Key outcomes included:
- Board Elections: Stockholders elected Steven Shum, Dr. Kevin Doody, Trent Davis, and Michael Campbell to the Board of Directors. Kathleen Karloff was defeated in her re-election bid, receiving more votes against than for.
- Reverse Stock Split: Stockholders approved an amendment to the certificate of incorporation to effect a reverse stock split of outstanding common stock at a ratio between 1-for-5 and 1-for-25. The exact ratio and effective time are at the Board's discretion.
- Accounting Firm: Stockholders ratified the selection of M&K CPAS, PLLC as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
- Compensation Plan: Stockholders approved the Company's 2019 Stock Incentive Plan.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, or specific risks. The approval of the reverse stock split suggests a strategic move to adjust the share structure, potentially to meet listing requirements or improve marketability, though the specific rationale is not detailed in this text.
Investor Verification Checklist
- Verify the exact reverse stock split ratio and effective date once determined by the Board.
- Review the composition of the new Board of Directors following the election results.
- Confirm the terms and share limits of the newly approved 2019 Stock Incentive Plan.
- Monitor future filings for the Company's financial statements for the fiscal year ending December 31, 2019, as this 8-K does not contain financial data.